Egbert Vincent Madamba • UCSD Profiles (original) (raw)
- The MetALD-ALD Prediction Index: A Phosphatidylethanol-Driven Biomarker Panel for Identifying Individuals With Steatotic Liver Disease and Excessive Alcohol Use. Gastroenterology. 2026 Feb 25. Tavaglione F, Vaz J, Jamialahmadi O, Díaz LA, Ajmera V, Contrano D, Madamba E, Singh S, Bettencourt R, Richards L, Hagström H, Loomba R. PMID: 41739005.
View in: PubMed Mentions: Fields: - Clinical Utility of a 50% and 30% Decline in Magnetic Resonance Imaging-Proton Density Fat Fraction in Predicting Fibrosis Improvement in Metabolic Dysfunction-associated Steatohepatitis. Clin Gastroenterol Hepatol. 2026 Feb 06. Loomba R, Daniel PCN, Wang Y, Bettencourt R, Madamba E, Siddiqi H, Richards L, Gottwald MD, Feng S, Margalit M, Huang DQ. PMID: 41655805.
View in: PubMed Mentions: - Clinical Trial: Semaglutide Versus Placebo in NIT-Assessed MASH-A Multicenter Randomised Placebo-Controlled Trial (SAMARA). Aliment Pharmacol Ther. 2026 Jan 12. Ajmera V, Vuppalanchi R, Khalili M, Sheikh MY, Risser J, Klein S, Tincopa M, Madamba E, Singh S, Siddiqi H, Cortez-Moreno D, Contrano D, Hofflich H, Abeles R, Lunde O, Grunvald E, Bettencourt R, He F, Jain S, Richards L, Loomba R. PMID: 41527269.
View in: PubMed Mentions: Fields: - Factors associated with protection from MASLD in type 2 diabetes: A prospective study integrating longitudinal MRI/MRE and stable isotope tracing. JHEP Rep. 2026 Mar; 8(3):101733. Tavaglione F, Ajmera V, Díaz LA, Li K, Madamba E, Bettencourt R, Richards L, Hellerstein M, Loomba R. PMID: 41716746; PMCID: PMC12914784.
View in: PubMed Mentions: - Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Aliment Pharmacol Ther. 2026 Mar; 63(6):838-849. Tesfai K, Díaz LA, Arab JP, Arrese M, Idalsoaga F, Ayares G, Agrawal S, Barreyro FJ, Gadano A, Marciano S, Morales JM, Villela-Nogueira C, Leite N, Salles G, Cardoso CR, Couto CA, Theodoro R, de Sousa Dias Monteiro MJ, Oliveira CP, Pessoa MG, Alvares-da-Silva MR, Huang DQ, Madamba E, Singh S, Lokanadham S, Bettencourt R, Richards LM, Khera AV, Loomba R, Ajmera V. PMID: 41147688; PMCID: PMC12671836.
View in: PubMed Mentions: - Clinical utility of phosphatidylethanol to detect underreported alcohol use and enhance steatotic liver disease subclassification. J Hepatol. 2025 Nov; 83(5):1023-1034. Tavaglione F, Díaz LA, Ajmera V, Madamba E, Singh S, Bettencourt R, Richards L, Loomba R. PMID: 40517819.
View in: PubMed Mentions: 4 Fields:
Translation:Humans - Noninvasive pathway for stratifying fibrosis in suspected metabolic dysfunction and alcohol-associated liver disease (MetALD). Hepatol Commun. 2025 Jun 01; 9(6). Díaz LA, Tavaglione F, Mittal N, Bettencourt R, Amangurbanova M, Johnson A, Marti-Aguado D, Tincopa M, Loomba R, Khan-Riches A, Madamba E, Siddiqi H, Richards L, Sirlin CB, Ajmera V, Loomba R. PMID: 40377491; PMCID: PMC12088636.
View in: PubMed Mentions: 3 Fields:
Translation:Humans - Head-to-head comparison of MASH resolution index versus FAST for noninvasive prediction of resolution of MASH on biopsy. Hepatology. 2026 Apr 01; 83(4):907-914. Loomba R, Daniel PCN, Amangurbanova M, Bettencourt R, Madamba E, Siddiqi H, Richards L, Gottwald MD, Feng S, Margalit M, Huang DQ. PMID: 40359098.
View in: PubMed Mentions: 1 Fields: - High inherited risk predicts age-associated increases in fibrosis in patients with MASLD. J Hepatol. 2025 Oct; 83(4):849-859. Díaz LA, Alazawi W, Agrawal S, Arab JP, Arrese M, Idalsoaga F, Barreyro FJ, Gadano A, Marciano S, Martínez Morales J, Villela-Nogueira C, Leite N, Couto CA, Theodoro R, Monteiro MJSD, Oliveira CP, Pessoa MG, Alvares-da-Silva MR, Madamba E, Bettencourt R, Richards LM, Majithia AR, Khera AV, Loomba R, Ajmera V. PMID: 40334848; PMCID: PMC12453583.
View in: PubMed Mentions: 5 Fields:
Translation:Humans - Clinical Trial to Assess the Safety and Tolerability of Anti-IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol-Associated Liver Disease. Aliment Pharmacol Ther. 2025 Apr; 61(7):1140-1151. Diaz LA, Morris S, Dave S, Kim SM, Sarik W, Richards L, Madamba E, Bettencourt R, Fulinara C, Pham T, Miller G, Carvalho-Gontijo Weber R, Momper JD, He F, Jain S, Jamieson C, Kisseleva T, Brenner D, Loomba R. PMID: 39949265; PMCID: PMC12087978.
View in: PubMed Mentions: 2 Fields:
Translation:HumansCTClinical Trials - Head-to-Head Comparison Between Phosphatidylethanol Versus Indirect Alcohol Biomarkers for Diagnosis of MetALD Versus MASLD: A Prospective Study. Aliment Pharmacol Ther. 2025 Mar; 61(6):1043-1054. Tavaglione F, Amangurbanova M, Yang AH, Tincopa MA, Ajmera V, Richards L, Butcher C, Hernandez C, Madamba E, Singh S, Bettencourt R, Sirlin CB, Loomba R. PMID: 39825487; PMCID: PMC11870800.
View in: PubMed Mentions: 11 Fields:
Translation:Humans - Identification of Candidates for MASLD Treatment With Indeterminate Vibration-Controlled Transient Elastography. Clin Gastroenterol Hepatol. 2025 Jun; 23(7):1183-1193.e5. Marti-Aguado D, Carot-Sierra JM, Villalba-Ortiz A, Siddiqi H, Vallejo-Vigo RM, Lara-Romero C, Martín-Fernández M, Fernández-Patón M, Alfaro-Cervello C, Crespo A, Coello E, Merino-Murgui V, Madamba E, Benlloch S, Pérez-Rojas J, Puglia V, Ferrández A, Aguilera V, Monton C, Escudero-García D, Lluch P, Aller R, Loomba R, Romero-Gomez M, Marti-Bonmati L. PMID: 39551253.
View in: PubMed Mentions: 5 Fields:
Translation:Humans - Prevalence of steatotic liver disease, advanced fibrosis and cirrhosis among community-dwelling overweight and obese individuals in the USA. Gut. 2024 Nov 11; 73(12):2045-2053. Yang AH, Tincopa MA, Tavaglione F, Ajmera VH, Richards LM, Amangurbanova M, Butcher C, Hernandez C, Madamba E, Singh S, Bettencourt R, Schnabl B, Sirlin CB, Loomba R. PMID: 39117370.
View in: PubMed Mentions: 18 Fields:
Translation:Humans - A Prospective Study on the Prevalence of MASLD in Patients With Type 2 Diabetes and Hyperferritinaemia. Aliment Pharmacol Ther. 2025 Feb; 61(3):456-464. Amangurbanova M, Huang DQ, Noureddin N, Tesfai K, Bettencourt R, Siddiqi H, Lopez SJ, Cervantes V, Madamba E, Loomba R. PMID: 39499168.
View in: PubMed Mentions: 5 Fields:
Translation:Humans - Disparities in screening and risk stratification for Hispanic adults with metabolic dysfunction-associated steatotic liver disease. Hepatology. 2025 Jun 01; 81(6):1792-1804. Tincopa MA, Díaz LA, Huang DQ, Arab JP, Arrese M, Gadano A, Oliveira CP, Bettencourt R, Madamba E, Kim S, Siddiqi H, Barreyro FJ, Marciano S, Martínez Morales J, Villela-Nogueira C, Leite N, Couto CA, Theodoro R, Joyner de Sousa Dias Monteiro M, Pessoa MG, Alvares-da-Silva MR, Higuera de la Tijera F, Sabate CD, Mendizabal M, Richards L, Sirlin CB, Loomba R. PMID: 39423341; PMCID: PMC12006453.
View in: PubMed Mentions: 2 Fields:
Translation:HumansPHPublic Health - MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASH. Gut. 2024 07 11; 73(8):1343-1349. Loomba R, Amangurbanova M, Bettencourt R, Madamba E, Siddiqi H, Richards L, Behling C, Sirlin CB, Gottwald MD, Feng S, Margalit M, Huang DQ. PMID: 38418210; PMCID: PMC12355936.
View in: PubMed Mentions: 12 Fields:
Translation:Humans - Repeatability of vibration-controlled transient elastography versus magnetic resonance elastography in patients with cirrhosis: A prospective study. Aliment Pharmacol Ther. 2024 08; 60(4):484-491. Siddiqi H, Huang DQ, Mittal N, Nourredin N, Bettencourt R, Madamba E, Amangurbanova M, Hernandez C, Sirlin C, Yin M, Loomba R. PMID: 38863232; PMCID: PMC11618574.
View in: PubMed Mentions: 4 Fields:
Translation:Humans - The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes. Aliment Pharmacol Ther. 2024 08; 60(3):369-377. Bridi L, Agrawal S, Tesfai K, Madamba E, Bettencourt R, Richards LM, Khera AV, Loomba R, Ajmera V. PMID: 38825972; PMCID: PMC11236495.
View in: PubMed Mentions: 9 Fields:
Translation:Humans - A prospective study on the prevalence of at-risk MASH in patients with type 2 diabetes mellitus in the United States. Aliment Pharmacol Ther. 2024 06; 59(12):1571-1578. Mittal N, Siddiqi H, Madamba E, Richards L, Bettencourt R, Ajmera V, Loomba R. PMID: 38586922; PMCID: PMC12425555.
View in: PubMed Mentions: 7 Fields: - Effects of Food Insecurity on Hepatic Steatosis and Fibrosis in People With HIV. Clin Gastroenterol Hepatol. 2024 Jul; 22(7):1427-1435.e6. Kardashian A, Lloyd A, Vilar-Gomez E, Naggie S, Sulkowski MS, Woreta T, Lake JE, Crandall H, Loomba R, Wilson LA, Sterling RK, Heath S, Gawrieh S, Chalasani NP, Price JC, HIV NASH Clinical Research Network. PMID: 38582290; PMCID: PMC11193609.
View in: PubMed Mentions: 2 Fields: - Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality. Aliment Pharmacol Ther. 2024 01; 59(1):80-88. Lee SW, Huang DQ, Bettencourt R, Ajmera V, Tincopa M, Noureddin N, Amangurbanova M, Siddiqi H, Madamba E, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Yoneda M, Idilman R, Gumussoy M, Oz DK, Erden A, Loomba R. PMID: 37968251; PMCID: PMC10807727.
View in: PubMed Mentions: 4 Fields:
Translation:Humans - Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetes. Hepatology. 2024 05 01; 79(5):1098-1106. Ajmera V, Tesfai K, Sandoval E, Lopez S, Cervantes V, Madamba E, Bettencourt R, Manousou P, Richards L, Loomba R. PMID: 37862551; PMCID: PMC11023802.
View in: PubMed Mentions: 9 Fields:
Translation:Humans - Development and Validation of the Nonalcoholic Fatty Liver Disease Familial Risk Score to Detect Advanced Fibrosis: A Prospective, Multicenter Study. Clin Gastroenterol Hepatol. 2024 01; 22(1):81-90.e4. Huang DQ, Ahlholm N, Luukkonen PK, Porthan K, Amangurbanova M, Madamba E, Bettencourt R, Siddiqi H, Cervantes V, Hernandez C, Lopez SJ, Richards L, Nemes K, Isoniemi H, Yki-Järvinen H, Loomba R. PMID: 37406954; PMCID: PMC11160482.
View in: PubMed Mentions: 5 Fields:
Translation:Humans - Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLD. Aliment Pharmacol Ther. 2023 07; 58(2):229-237. Kim BK, Bernstein N, Huang DQ, Tamaki N, Imajo K, Yoneda M, Sutter N, Jung J, Nguyen K, Nguyen L, Le T, Madamba E, Richards L, Valasek MA, Behling C, Sirlin CB, Nakajima A, Loomba R. PMID: 37269117; PMCID: PMC10330628.
View in: PubMed Mentions: 5 Fields:
Translation:Humans - A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes. J Hepatol. 2023 03; 78(3):471-478. Ajmera V, Cepin S, Tesfai K, Hofflich H, Cadman K, Lopez S, Madamba E, Bettencourt R, Richards L, Behling C, Sirlin CB, Loomba R. PMID: 36410554; PMCID: PMC9975077.
View in: PubMed Mentions: 123 Fields:
Translation:Humans - Gut metagenome-derived signature predicts hepatic decompensation and mortality in NAFLD-related cirrhosis. Aliment Pharmacol Ther. 2022 11; 56(10):1475-1485. Sharpton SR, Oh TG, Madamba E, Wang C, Yu RT, Atkins AR, Huan T, Downes M, Evans RM, Loomba R. PMID: 36164267; PMCID: PMC9746351.
View in: PubMed Mentions: 4 Fields:
Translation:Humans - Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD. J Hepatol. 2022 12; 77(6):1482-1490. Kim BK, Tamaki N, Imajo K, Yoneda M, Sutter N, Jung J, Lin T, Tu XM, Bergstrom J, Nguyen K, Nguyen L, Le T, Madamba E, Richards L, Valasek MA, Behling C, Sirlin CB, Nakajima A, Loomba R. PMID: 35973577.
View in: PubMed Mentions: 41 Fields:
Translation:Humans - Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD. Radiology. 2022 07; 304(1):75-82. Jung J, Han A, Madamba E, Bettencourt R, Loomba RR, Boehringer AS, Andre MP, Erdman JW, O'Brien WD, Fowler KJ, Sirlin CB, Loomba R. PMID: 35348378; PMCID: PMC9270678.
View in: PubMed Mentions: 19 Fields:
Translation:Humans - Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease. Ther Adv Gastroenterol. 2021; 14:17562848211050436. Sharpton SR, Tamaki N, Bettencourt R, Madamba E, Jung J, Liu A, Behling C, Valasek MA, Loomba R. PMID: 34646360; PMCID: PMC8504217.
View in: PubMed Mentions: 17 - Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2021 05; 53(9):1030-1037. Park JG, Jung J, Verma KK, Kang MK, Madamba E, Lopez S, Qas Yonan A, Liu A, Bettencourt R, Sirlin C, Loomba R. PMID: 33764550; PMCID: PMC8514119.
View in: PubMed Mentions: 24 Fields:
Translation:Humans - MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis. Gut. 2021 10; 70(10):1946-1953. Jung J, Loomba RR, Imajo K, Madamba E, Gandhi S, Bettencourt R, Singh S, Hernandez C, Valasek MA, Behling C, Richards L, Fowler K, Sirlin CB, Nakajima A, Loomba R. PMID: 33214165; PMCID: PMC8131405.
View in: PubMed Mentions: 68 Fields:
Translation:Humans
Start with: newest oldestInclude: line numbers double spacing all authors publication IDs